National Speakers
Depto de Farmacologia - Universidade Federal de Santa Cataria
Titulo: Estado da arte da terapia com ácidos nucleicos na oncologia: evidências e desafios.
Instituição: Pontifícia Universidade Católica do Rio de Janeiro
Título da palestra: Planejamento Racional de Inibidores e Silenciadores de Genes Associados ao Câncer Usando Inteligência Artificial
FMRP-USP
Patient outcomes (efficacy, toxicity – CRS/ICANS)
Manufacturing/logistics challenges
Access barriers in Latin America
Lessons learned from clinical practice
FMRP-USP
Rationale for NK vs T cells
CD33 as a target (AML context)
Advantages: lower toxicity, off-the-shelf potential
FMRP-USP
Concept of immune reset (e.g., CAR-T targeting B cells)
Clinical results (e.g., lupus, multiple sclerosis)
Differences vs oncology: lower cell dose, different endpoints (remission vs cytotoxicity)
Safety considerations
Universidade Federal de Minas Gerais (UFMG)
Título: Imunoterapia do câncer baseada em nanopartículas lipídicas para entrega de ácidos nucleicos
Professor de Anatomia Humana da Universidade Estadual de Campinas (UNICAMP)
Regulations for submitting abstracts to Cel-Gen 2026
Submission opening and closing date/time:
Opening: June 1st
Closing: June 30, 12:00 a.m. (midnight)
Maximum number of abstracts per author: 3 abstracts
Maximum number of authors per abstract: 10 authors
Title length limit: 250 characters (including spaces)
Abstract length limit: Abstracts are limited to 3,000 characters, including punctuation and spaces (excluding title, authors, and affiliations)
Authors may submit abstracts before completing registration/payment. Registration fees will only be required after abstract acceptance.
Evaluation score/rating scale: up to 6 points
Work presentation formats: Poster and Oral Presentation
Categories:
Questions: contact@abtcelgen.org.br; temalivre3@mezclaeventos.com.br